# Advisor Review - GPT-5.4 (R2)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-08T01:10:47.712471
**Route:** OpenRouter + LaTeX
**Paper Hash:** 470df9b48290fea8
**Tokens:** 16065 in / 2374 out
**Response SHA256:** e6752678ff318b29

---

I checked the paper for fatal errors in the four requested categories only: data-design alignment, regression sanity, completeness, and internal consistency.

Findings:
- **Data-design alignment:** No fatal timing mismatch. The treatment begins in 2022 and the main data window runs through December 2023, so post-treatment data exist. The paper explicitly discloses that Czechia and Türkiye have no post-treatment observations and treats this consistently.
- **Regression sanity:** I found no obviously broken regression outputs. Coefficients and standard errors in all reported tables are numerically plausible for the stated outcomes. No impossible values (negative SEs, out-of-range \(R^2\), NA/NaN/Inf) appear in the reported results.
- **Completeness:** The paper appears complete. Regression tables report observations and standard errors. I found no placeholder entries (TBD, XXX, NA, etc.), empty numeric cells requiring estimates, or references to nonexistent tables/figures.
- **Internal consistency:** The main numeric claims in text are consistent with the tables (e.g., \(-0.231/0.433 \approx -0.53\), and \(-0.231 \times 0.097 \approx -0.022\)). Timing statements about the treatment window and post period are internally consistent across sections and appendix.

ADVISOR VERDICT: PASS